Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
SpringerBriefs in Biotech Patents present timely reports of intellectual properties (IP) issues and patent aspects in the field of biotechnology. This new volume in the series focuses on the particular IP issues of therapeutics, vaccines and molecular diagnostics. The first chapter concentrates on basics principles for protecting antibody compounds. Additional ways to create follow-up protection for antibody therapeutics are also discussed. The second chapter gives an overview of the patent landscape in molecular diagnostics, and discusses issues of patentability with respect to the different technologies and compounds used therein. The third chapter gives a broad overview of areas of law that are particularly relevant to the patenting of peptide vaccines and therapeutic peptides as products and in compositions. The scope of patentable subject matter is discussed, as it has been the focus of much wrangling and debate in the courts.
Drugs -- Patents. --- Intellectual property (International law). --- Patent laws and legislation -- China. --- Patent laws and legislation -- Molecular diagnosis. --- Patent laws and legislation -- United States. --- Pharmaceutical biotechnology --- Drugs --- Patent laws and legislation --- Intellectual property (International law) --- Law, Politics & Government --- Biology --- Health & Biological Sciences --- Law, General & Comparative --- Cytology --- Molecular diagnosis --- Biotechnology --- Intellectual property. --- Intellectual property --- IP (Intellectual property) --- Proprietary rights --- Rights, Proprietary --- Law and legislation --- Life sciences. --- Antibodies. --- Vaccines. --- Pharmaceutical technology. --- Biotechnology. --- Cell biology. --- Commercial law. --- Life Sciences. --- Cell Biology. --- Pharmaceutical Sciences/Technology. --- Vaccine. --- Commercial Law. --- Intangible property --- Biopiracy --- Cytology. --- Monoclonal antibodies. --- Business --- Business law --- Commerce --- Law, Commercial --- Mercantile law --- Law --- Law merchant --- Maritime law --- Biologicals --- Antibodies, Monoclonal --- Monoclonal immunoglobulins --- Immunoglobulins --- Molecular cloning --- Chemical engineering --- Genetic engineering --- Pharmaceutical laboratory techniques --- Pharmaceutical laboratory technology --- Technology, Pharmaceutical --- Technology --- Cell biology --- Cellular biology --- Cells --- Cytologists --- Antibodies --- Immune globulins --- Immune serum globulin --- Blood proteins --- Globulins --- Plasma cells --- Antibody diversity --- Antigens --- Bacterial immunoglobulin-binding proteins
Choose an application
Patents protecting biotechnological invention become ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.
Biotechnology -- Law and legislation. --- Biotechnology -- Patents. --- Biotechnology. --- Biotechnology --- Biology --- Law, Politics & Government --- Health & Biological Sciences --- Cytology --- Law, General & Comparative --- Law and legislation --- Law and legislation. --- Life sciences. --- Pharmaceutical technology. --- Biochemistry. --- Cell biology. --- Microbiology. --- Commercial law. --- Life Sciences. --- Cell Biology. --- Pharmaceutical Sciences/Technology. --- Biochemistry, general. --- Commercial Law. --- Biopiracy --- Cytology. --- Chemical engineering --- Genetic engineering --- Business --- Business law --- Commerce --- Law, Commercial --- Mercantile law --- Law --- Law merchant --- Maritime law --- Biological chemistry --- Chemical composition of organisms --- Organisms --- Physiological chemistry --- Chemistry --- Medical sciences --- Pharmaceutical laboratory techniques --- Pharmaceutical laboratory technology --- Technology, Pharmaceutical --- Technology --- Cell biology --- Cellular biology --- Cells --- Cytologists --- Microbial biology --- Microorganisms --- Composition
Choose an application
SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer’s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.
Biotechnology --- Law and legislation. --- Biotechnology -- Law and legislation -- European Union countries. --- Biotechnology -- Law and legislation -- United States. --- Technological innovations -- Patents. --- Life sciences. --- Medical genetics. --- Genetic engineering. --- Nucleic acids. --- Stem cells. --- Plant breeding. --- Commercial law. --- Life Sciences. --- Stem Cells. --- Gene Function. --- Plant Breeding/Biotechnology. --- Nucleic Acid Chemistry. --- Genetic Engineering. --- Commercial Law. --- Business --- Business law --- Commerce --- Law, Commercial --- Mercantile law --- Law --- Law merchant --- Maritime law --- Crops --- Agriculture --- Breeding --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Cells --- Polynucleotides --- Biomolecules --- Designed genetic change --- Engineering, Genetic --- Gene splicing --- Genetic intervention --- Genetic surgery --- Genetic recombination --- Transgenic organisms --- Clinical genetics --- Diseases --- Heredity of disease --- Human genetics --- Medical sciences --- Pathology --- Genetic disorders --- Biosciences --- Sciences, Life --- Science --- Law and legislation --- Genetic aspects --- Biopiracy
Choose an application
Patents protecting biotechnological invention become ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.
Commercial law --- General microbiology --- Histology. Cytology --- General biochemistry --- Pharmacology. Therapy --- Biotechnology --- farmacologie --- biochemie --- handelsrecht --- microbiologie --- biotechnologie --- cytologie --- histologie
Choose an application
Commercial law --- Histology. Cytology --- Pharmacology. Therapy --- Medical microbiology, virology, parasitology --- Biotechnology --- vaccins --- farmacologie --- handelsrecht --- biotechnologie --- cytologie --- vaccinatie --- histologie --- moleculaire biologie
Choose an application
SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer’s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.
Commercial law --- Organic chemistry --- Genetics --- Histology. Cytology --- Molecular biology --- Biology --- Botany --- Human genetics --- Agriculture. Animal husbandry. Hunting. Fishery --- Biotechnology --- systematische plantkunde --- RNA (ribonucleic acid) --- nucleïnezuren --- organische chemie --- medische genetica --- stamcellen --- biologie --- bevolking --- handelsrecht --- genetica --- biotechnologie --- genetische manipulatie --- stamceltransplantatie --- DNA (deoxyribonucleic acid) --- moleculaire biologie
Choose an application
SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.
Biotechnology --- Law and legislation --- Medicine. --- Molecular biology. --- Biochemistry. --- International law. --- Intellectual property --- Biomedicine. --- Molecular Medicine. --- International IT and Media Law, Intellectual Property Law. --- Biochemistry, general. --- Law and legislation. --- Chemical engineering --- Genetic engineering --- Mass media --- IT Law, Media Law, Intellectual Property. --- Biological chemistry --- Chemical composition of organisms --- Organisms --- Physiological chemistry --- Biology --- Chemistry --- Medical sciences --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Pathology --- Physicians --- Composition --- Mass media. --- Law. --- Acts, Legislative --- Enactments, Legislative --- Laws (Statutes) --- Legislative acts --- Legislative enactments --- Jurisprudence --- Legislation --- Mass communication --- Media, Mass --- Media, The --- Communication --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Medicine --- Information technology --- Biomedical Research. --- Research. --- Technology and law --- Biological research --- Biomedical research --- Health Workforce --- Patents.
Choose an application
SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.
International law --- General biochemistry --- Molecular biology --- Pathological biochemistry --- Human medicine --- Mass communications --- Computer. Automation --- medische biochemie --- mediaregies --- biochemie --- biomedische wetenschappen --- biotechnologie --- internationaal recht --- moleculaire biologie --- Biotechnology --- Law and legislation
Choose an application
Patents protecting biotechnological invention become ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.
Commercial law --- General microbiology --- Histology. Cytology --- General biochemistry --- Pharmacology. Therapy --- Biotechnology --- farmacologie --- biochemie --- handelsrecht --- microbiologie --- biotechnologie --- cytologie --- histologie
Choose an application
Commercial law --- Histology. Cytology --- Pharmacology. Therapy --- Medical microbiology, virology, parasitology --- Biotechnology --- vaccins --- farmacologie --- handelsrecht --- biotechnologie --- cytologie --- vaccinatie --- histologie --- moleculaire biologie
Listing 1 - 10 of 11 | << page >> |
Sort by
|